{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:46:27Z","timestamp":1776260787891,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cger.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T14:12:51Z","timestamp":1618323171000},"page":"301-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Paraproteinemias and Peripheral Nerve Disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Yaowaree","family":"Leavell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cger.2021.01.004_bib1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.24471","article-title":"Paraproteinemic neuropathies","volume":"51","author":"Raheja","year":"2015","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11910-011-0237-4","article-title":"An update on monoclonal gammopathy and neuropathy","volume":"12","author":"Ramchandren","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.cger.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cger.2021.01.004_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/01.CON.0000455879.99050.26","article-title":"Paraproteinemic neuropathies","volume":"20","author":"Mauermann","year":"2014","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"10.1016\/j.cger.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1038\/s41598-019-42545-8","article-title":"Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy","volume":"9","author":"Pascual-Go\u00f1i","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","article-title":"Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features","volume":"89","author":"Svahn","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cger.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.009","article-title":"Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment","volume":"281","author":"Campagnolo","year":"2015","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.cger.2021.01.004_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617746640","article-title":"Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies","volume":"11","author":"Dalakas","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"10","key":"10.1016\/j.cger.2021.01.004_bib11","article-title":"Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","author":"Lunn","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.1016\/j.cger.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"L\u00e9ger","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cger.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11940-017-0479-9","article-title":"Advances in the treatment of paraproteinemic neuropathy","volume":"19","author":"Nobile-Orazio","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/WCO.0000000000000726","article-title":"Neuropathies and paraproteins","volume":"32","author":"Lunn","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"10.1016\/j.cger.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp-2017-315736","article-title":"IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy","volume":"88","author":"Campagnolo","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.cger.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrneurol.2014.117","article-title":"Diagnosis and treatment of chronic acquired demyelinating polyneuropathies","volume":"10","author":"Latov","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.cger.2021.01.004_bib17","first-page":"CD005376","article-title":"Treatment for IgG and IgA paraproteinaemic neuropathy","author":"Stork","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cger.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0317167100011483","article-title":"The neuropathies of Waldenstr\u00f6m's macroglobulinemia (WM) and IgM-MGUS","volume":"38","author":"Klein","year":"2011","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1529-8027.2012.00376.x","article-title":"Heterogeneous spectrum of neuropathies in Waldenstr\u00f6m's macroglobulinemia: a diagnostic strategy to optimize their management","volume":"17","author":"Viala","year":"2012","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.cger.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp.2005.071175","article-title":"Peripheral neuropathies in Waldenstr\u00f6m's macroglobulinaemia","volume":"77","author":"Levine","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.cger.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamaoncol.2016.5763","article-title":"Diagnosis and management of waldenstr\u00f6m macroglobulinemia: mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) Guidelines 2016","volume":"3","author":"Kapoor","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2417","article-title":"Diagnosis and management of neuropathies associated with plasma cell dyscrasias","volume":"36","author":"Rosenbaum","year":"2018","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hoc.2017.09.010","article-title":"POEMS syndrome: diagnosis and investigative work-up","volume":"32","author":"Dispenzieri","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp-2011-301472","article-title":"Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP","volume":"83","author":"Mauermann","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"19","key":"10.1016\/j.cger.2021.01.004_bib26","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1212\/WNL.0000000000001565","article-title":"Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome","volume":"84","author":"Karam","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cger.2021.01.004_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.2149","article-title":"Therapy-related peripheral neuropathy in multiple myeloma patients","volume":"33","author":"Morawska","year":"2015","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib28","first-page":"249","article-title":"'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma","volume":"76","author":"Rutten","year":"2018","journal-title":"Neth J Med"},{"issue":"9","key":"10.1016\/j.cger.2021.01.004_bib29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","article-title":"AL amyloidosis: advances in diagnostics and treatment","volume":"34","author":"Ry\u0161av\u00e1","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnen\/64.5.386","article-title":"IgG neuropathy: an immunoelectron microscopic study","volume":"64","author":"Vallat","year":"2005","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0039-1688994","article-title":"Neuropathy associated with systemic amyloidosis","volume":"39","author":"Kaku","year":"2019","journal-title":"Semin Neurol"},{"issue":"12","key":"10.1016\/j.cger.2021.01.004_bib32","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cardfail.2016.10.008","article-title":"Transthyretin cardiac amyloidosis in older Americans","volume":"22","author":"Brunjes","year":"2016","journal-title":"J\u00a0Card Fail"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/CS20160413","article-title":"Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy","volume":"131","author":"Galant","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"22","key":"10.1016\/j.cger.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10038","key":"10.1016\/j.cger.2021.01.004_bib35","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cger.2021.01.004_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12153","article-title":"Red-flag\" symptom clusters in transthyretin familial amyloid polyneuropathy","volume":"21","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"J\u00a0Peripher Nerv Syst"},{"issue":"4","key":"10.1016\/j.cger.2021.01.004_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1212\/CPJ.0000000000000640","article-title":"Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis","volume":"9","author":"Karam","year":"2019","journal-title":"Neurol Clin Pract"},{"issue":"2","key":"10.1016\/j.cger.2021.01.004_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.rdc.2013.02.012","article-title":"Amyloidosis: a clinical overview","volume":"39","author":"Hazenberg","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.cger.2021.01.004_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ane.13035","article-title":"Hereditary transthyretin-related amyloidosis","volume":"139","author":"Finsterer","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.cger.2021.01.004_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp-2016-315262","article-title":"Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy","volume":"88","author":"Cortese","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.cger.2021.01.004_bib41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/practneurol-2018-002098","article-title":"Diagnosis of amyloid neuropathy","volume":"19","author":"Kapoor","year":"2019","journal-title":"Pract Neurol"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:59Z","timestamp":1760061419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069021000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0749069021000045"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2021.01.004","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraproteinemias and Peripheral Nerve Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}